A Case of Immune-Mediated Pneumonitis Associated With Dual Nivolumab and Ipilimumab Immunotherapy Treatment

Nivolumab and ipilimumab are immunotherapy agents used in combination to treat metastatic melanoma and have proven to be efficacious. However, they have been linked to the development of immune-mediated inflammatory processes in various organ systems and tissues, including immune-mediated pneumoniti...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Saghir, Tala, Suleiman, Noor, Goodman, Benjamin D, Ferguson, Michael W, Tejwani, Sheela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362781/
https://www.ncbi.nlm.nih.gov/pubmed/37485100
http://dx.doi.org/10.7759/cureus.40792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362781/
https://www.ncbi.nlm.nih.gov/pubmed/37485100
http://dx.doi.org/10.7759/cureus.40792

Ejemplares similares